MarketPeel
Insider Trading Intelligence
Pricing
…
AI

A2a Pharmaceuticals, Inc.

BMEA
10% OWNER · BIOMEA FUSION, INC. · CIK 0001859061
FILING MIX · LIFETIME17%/83%
BUYS
2
SELLS
10
TOTAL VALUE
$33.61M
COMPANIES
1
ACTIVE SINCE
Sep 2021
HOLDINGS NOW
3,500,000
AVG SELL PX
$29.98
TRADE KIND
SHOWING 12 / 12
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by A2a Pharmaceuticals, Inc., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+63.64%-2.82%+0.09%-2.91%-4.43%—
14d11+63.64%-5.99%+0.90%-6.88%-8.74%—
30d11+54.55%-2.37%+2.53%-4.90%+0.76%—
60d11+81.82%-16.08%+3.59%-19.67%-17.07%—
90d11+90.91%-36.61%+4.62%-41.23%-37.91%—
180d11+90.91%-55.64%+4.71%-60.34%-67.59%—
1y11+63.64%-22.13%+22.74%-44.88%-84.91%—
2y11+90.91%-84.09%+40.45%-124.54%-133.51%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BMEA · 3,500,000 shares · as of Jun 1, 2023
01,100,0002,200,0003,300,0004,400,00020222023SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2022
2022
2022
2022
2023
2023
FLOW · 2 buys / 10 sellsCOVERAGE · 8 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BMEA
BIOMEA FUSION, INC.
SALE
50,000$34.56$1.73M3,500,000Jun 1, 2023Jun 2, 2023 ↗View →
BMEA
BIOMEA FUSION, INC.
SALE
75,000$33.81$2.54M3,550,000May 31, 2023Jun 2, 2023 ↗View →
BMEA
BIOMEA FUSION, INC.
SALE
25,000$33.84$846.0K3,625,000May 12, 2023May 17, 2023 ↗View →
BMEA
BIOMEA FUSION, INC.
SALE
150,000$34.50$5.18M3,650,000May 9, 2023May 10, 2023 ↗View →
BMEA
BIOMEA FUSION, INC.
SALE
100,000$33.99$3.40M3,800,000May 8, 2023May 10, 2023 ↗View →
BMEA
BIOMEA FUSION, INC.
SALE
200,000$29.12$5.82M3,900,000Apr 20, 2023Apr 25, 2023 ↗View →
BMEA
BIOMEA FUSION, INC.
PURCHASE
200,000$31.25$6.25M4,100,000Mar 31, 2023Apr 6, 2023 ↗View →
BMEA
BIOMEA FUSION, INC.
SALE
200,000$31.25$6.25M4,100,000Mar 31, 2023Apr 6, 2023 ↗View →
BMEA
BIOMEA FUSION, INC.
SALE
30,684$13.87$425.6K4,300,000Aug 16, 2022Aug 19, 2022 ↗View →
BMEA
BIOMEA FUSION, INC.
SALE
34,658$11.21$388.5K4,330,684Jul 21, 2022Jul 25, 2022 ↗View →
BMEA
BIOMEA FUSION, INC.
SALE
34,658$11.76$407.6K4,365,342Jun 24, 2022Jun 28, 2022 ↗View →
BMEA
BIOMEA FUSION, INC.
PURCHASE
34,658$10.96$379.9K4,400,000Sep 17, 2021Sep 21, 2021 ↗View →
Other insiders · BMEA
Loading peer insiders…
About this filer
CIK 0001859061
ROLE
10% Owner
PRIMARY
BMEA
COMPANIES
1
ACTIVE SINCE
Sep 2021
MARKETPEEL · /INSIDER/0001859061DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback